Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes

By sjmartinez • June 2, 2023

Essien UR, Singh B, Swabe G, Johnson AE, Eberly LA, Wadhera RK, Breathett K, Vaduganathan M, Magnani JW. Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes. JAMA Netw Open. 2023 Jun 1;6(6):e2316290. doi: 10.1001/jamanetworkopen.2023.16290. PMID: 37261826.

Tags: General Internal Medicine, Publications, Veterans Administration

“The Patient”

Thure KA. "The Patient". JAMA. 2024 Apr 18. doi: 10.1001/jama.2024.3082. Epub ahead of print. PMID: 38635227.

Unique features of dyslipidemia in women across a lifetime and a tailored approach to management

Patel N, Mittal N, Wilkinson MJ, Taub PR. Unique features of dyslipidemia in women across a lifetime and a tailored approach to management. Am J[...]

Statin use for cardiovascular disease prevention: perceptions among people living with HIV in the United States

Ogunbajo A, Todd I, Zajdman D, Anderson A, Wali S, Diamant A, Ladapo JA, Ober AJ. Statin use for cardiovascular disease prevention: perceptions among people[...]